About Norlase
Norlase is a Technology company based in Ballerup (Denmark) founded in 2014 by Oliver Hvidt. Provider of low-level laser therapy systems. Norlase has raised $11 million across 14 funding rounds from investors including European Investment Bank, European Union and West Hill Capital. The company has 31 employees. Its chief executive, as recorded, is Oliver Hvidt. Norlase offers products and services including LYNX, ECHO, LION, and LEAF. Its focus areas include Semiconductors, Photonics, Biophotonics and Light Therapy. Its legal entity is Norlase ApS.
Company details
Norlase was founded in 2014 in Ballerup, Denmark, as a provider of low-level laser therapy systems within the ophthalmology sector. Green laser solutions have been developed for treating retina and glaucoma diseases. The product portfolio includes indirect ophthalmoscopes integrated with green laser sources, along with green laser photocoagulators. Operations focus on medical device innovation for eye care applications.
- Headquarters Ballerup, Denmark
- Employees 31
- Founders Oliver Hvidt
- SectorsTechnology
- Email••••••••
- Phone•••• ••••
- Website norlase.com
- Social LinkedIn X Facebook Instagram
- Legal Name Norlase Aps
- Annual Revenue$678.15 (USD)1387as on Dec 31, 2017
- Net Profit-$4.63 M (USD)-35as on Dec 31, 2022
- EBITDA-$4.99 M (USD)-35as on Dec 31, 2022
- Total Equity Funding$11M (USD)
in 14 rounds
- Latest Funding Round$20.9M (USD), Debt – Conventional
Mar 2025
- InvestorsEuropean Investment Bank
& 3 more
- Employee Count31
Products & Services of Norlase
Norlase offers a comprehensive portfolio of products and services, including LYNX, ECHO, LION, and LEAF.
Portable device for pattern scanning laser eye treatments.
Compact system combining laser engine with MEMS technology for portability.
Battery-powered device with wireless interface for flexible eye treatments.
Attachable system for slit lamps without external fibers or carts.
Funding Insights of Norlase
Norlase has successfully raised a total of $11M across 14 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $20.9 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11M
- Total Rounds 14
- Last Round Debt – Conventional — $20.9M
- Investors Count 4
Latest 10 of 14 funding rounds of Norlase with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $20.9M | Debt – Conventional | – | – | |
| May 2023 | $11M | Series B | – | West Hill Capital | – |
| Apr 2020 | Series A | – | – | – | |
| Mar 2019 | $1.6M | Grant | – | – | |
| Jan 2019 | Seed | – | – | – | |
| Oct 2018 | Seed | – | – | – | |
| Sep 2017 | $136,141 | Grant | – | – | |
| Jan 2017 | $121,522 | Grant | – | – | |
| Oct 2016 | $1.33M | Grant | – | – | |
| Mar 2016 | Seed | – | – | – |
4 investors in total: 4 institutional.
Investors in Norlase
Norlase has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank, European Union and West Hill Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Finance and advisory services for infrastructure projects are provided. | 1958 | eib.org | Luxembourg, Luxembourg | |
Growth-stage venture capital investments are provided by West Hill Capital. | westhillcapital.co.uk | London, United Kingdom | ||
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Norlase
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Norlase
20 people are tracked at Norlase (8 in leadership, 12 in team); the tracked headcount is 31.
| Name | Role | Group |
|---|---|---|
Oliver Hvidt | Co-Founder & CEO | Leadership |
Uri Shabto | Leadership | |
Scott Griger | Sales Director - US | Leadership |
Taoufiq Jellal | Vice President Global Distribution | Leadership |
Danny Noordegraaf | CTO | Leadership |
Guillermo L Molina | Senior Regional Director, Latin America & Canada | Leadership |
Peter M. W. Skovgaard | SCO - Chief Scientific Officer | Leadership |
Peter Isaksson | Chief Operating Officer | Leadership |
Christian Lykke Salling | Supply Chain Manager | Team |
Dorthe Dyreborg | Office Manager | Team |
Izabela Strømsborg | Quality Engineer | Team |
Christian Nygaard Pedersen | Mechanical Engineer | Team |
Thomas Buß | Laser Development Engineer | Team |
Troy Gerber | Midwest Regional Sales Manager | Team |
Bjarke Gøth | Electronics engineer | Team |
Tobias Wilken | Electronic Engineer | Team |
Mariafernanda Vilera | R & D Project Manager | Team |
Sidsel Papior | Manufacturing Development Manager | Team |
James Brumm | West Coast Region Sales Manager | Team |
Emil Breum Eriksen | Test and Automation Engineer | Team |
Complete people profiles for Norlase
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Norlase
3 dated milestones of Norlase across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Norlase is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Conventional, of $20.9M.
Web traffic of Norlase
The website of Norlase (norlase.com) receives about 8.8K visits a month.
- Monthly visits8.8K
▲ 3.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Norlase
Complete news archive for Norlase
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Norlase
Norlase was founded in 2014.
Norlase is headquartered in Ballerup, Denmark.
Oliver Hvidt is the CEO of Norlase, as recorded in our data. They have also founded this company.
Norlase is a funded company, having raised a total of $11M across 14 funding rounds to date.
Norlase has 31 employees.
Annual revenue of Norlase is $678.15 as on Dec 31, 2017.
Norlase was founded in 2014 in Ballerup, Denmark, as a provider of low-level laser therapy systems within the ophthalmology sector. Green laser solutions have been developed for treating retina and glaucoma diseases. The product portfolio includes indirect ophthalmoscopes integrated with green laser sources, along with green laser photocoagulators. Operations focus on medical device innovation for eye care applications.
Norlase offers LYNX, ECHO, LION, and LEAF.
Norlase has 4 investors. Key investors include European Investment Bank, European Union, West Hill Capital, and EIC Fund.
Norlase operates through Norlase Aps.